Literature DB >> 12946521

Microbubble responses to a similar mechanical index with different real-time perfusion imaging techniques.

Thomas R Porter1, Joseph Oberdorfer, Patrick Rafter, John Lof, Feng Xie.   

Abstract

The purpose of this study was to determine differences in contrast enhancement and microbubble destruction rates with current commercially available low-mechanical index (MI) real-time perfusion imaging modalities. A tissue-mimicking phantom was developed that had vessels at 3 cm (near field) and 9 cm (far field) from a real-time transducer. Perfluorocarbon-exposed sonicated dextrose albumin microbubbles (PESDA) were injected proximal to a mixing chamber, and then passed through these vessels while the region was insonified with either pulses of alternating polarity with pulse inversion Doppler (PID) or pulses of alternating amplitude by power modulation (PM) at MIs of 0.1, 0.2 and 0.3. Effluent microbubble concentration, contrast intensity and the slope of digital contrast intensity vs. time were measured. Our results demonstrated that microbubble destruction already occurs with PID at an MI of 0.1. Contrast intensity seen with PID was less than with PM. Therefore, differences in contrast enhancement and microbubble destruction rates occur at a similar MI setting when using different real-time pulse sequence schemes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12946521     DOI: 10.1016/s0301-5629(03)00900-1

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  2 in total

1.  Needle size and injection rate impact microbubble contrast agent population.

Authors:  Esra Talu; Robert L Powell; Marjorie L Longo; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2008-03-04       Impact factor: 2.998

Review 2.  Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering.

Authors:  Shengping Qin; Charles F Caskey; Katherine W Ferrara
Journal:  Phys Med Biol       Date:  2009-02-19       Impact factor: 3.609

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.